ArticleKardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery2019
Sensitivity and prognostic value of thyroid transcription factor-1 and napsin A in primary adenocarcinoma of the lung.
Article in Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Lung cancer has been the most common cause of cancer deaths in the past few decades worldwide. In the differentiation of the histopathological types, two basic markers are currently used, which are napsin A and thyroid transcription factor-1 (TTF-1). Aim: To assess the sensitivity of TTF-1, napsin A and combined use of both markers in detecting primary lung adenocarcinoma. The second aim was to examine the role of TTF-1 and napsin A both alone and in combination as prognostic markers. Material and methods: In the course of the study, patients' data were collected and histological specimens were evaluated using TTF-1 and napsin A as cancer markers. Results: The sensitivities for TTF-1 and napsin A when used separately were 74.58% and 49.15% respectively. When a panel of both TTF-1 and napsin A was used the sensitivity increased to 79.17% as 38 out of 48 cases were positive for either or both of the immunohistochemical markers. The results for 1-, 3-, 4-year survival data were 87.9%, 70.7 %, 58.6%, with TTF-1 positive patients having better survival. Conclusions: We have shown that both TTF-1 and napsin A are sensitive markers of primary lung adenocarcinoma with TTF-1 being more sensitive. Sensitivity increases when both markers are used in combination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.